<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38541324</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">325</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21030325</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has resulted in a growing number of patients experiencing persistent symptoms and physiological changes after recovering from acute SARS-CoV-2 infection, known as Long COVID. Long COVID is characterized by recurring symptoms and inflammation across multiple organ systems. Diagnosis can be challenging, influenced by factors like demographics, comorbidities, and immune responses. Long COVID impacts various organ systems and can have neuropsychological effects. Health disparities, particularly related to race, contribute to a higher burden of infection and ongoing symptoms in minority populations. Managing Long COVID entails addressing a spectrum of symptoms that encompass physical, cognitive, and psychological aspects. The recovery period for patients with Long COVID can vary significantly, influenced by factors like the severity of the disease, hospitalization, comorbidities, and age. Currently, there are no universally effective treatments, although certain interventions show promise, necessitating further research. Self-management and rehabilitation programs can provide relief, but more research is needed to establish their effectiveness. Preventive measures such as vaccination and the use of antiviral medications and metformin. It is imperative to conduct further research to develop evidence-based guidelines and gain a better understanding of the long-term implications of COVID-19. Long COVID could have substantial economic impact on the labor market, productivity, healthcare expenditures, and overall economic growth. To address the challenges patients with long-term complications face, there is a focus on strategies like promoting telework and flexible work arrangements to accommodate diverse symptoms, particularly chronic fatigue and other Long COVID effects. In conclusion, this review emphasizes the multifaceted complexity of Long COVID and the ongoing need to address its potential long-term health and economic impacts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sweis</LastName><ForeName>Jaleel Jerry G</ForeName><Initials>JJG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnaimat</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5574-2939</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Rheumatology, School of Medicine, University of Jordan, Amman 11942, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esparza</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Supritha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azam</LastName><ForeName>Abeera</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75701, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Zeel</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Awqati</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jetanalin</LastName><ForeName>Pim</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweis</LastName><ForeName>Nadia J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-1122-3264</Identifier><AffiliationInfo><Affiliation>Department of Business Administration, King Talal School of Business Technology, Princess Sumaya University for Technology, Amman 11942, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascoli</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Critical Care Sleep and Allergy, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novak</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, University of Illinois, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubinstein</LastName><ForeName>Israel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3628-0601</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Critical Care Sleep and Allergy, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papanikolaou</LastName><ForeName>Ilias C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Sarcoidosis Clinic, Corfu General Hospital, 49100 Corfu, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweiss</LastName><ForeName>Nadera</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, University of Jordan, Amman 11942, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091682" MajorTopicYN="N">Health Inequities</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">economics</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">health disparities</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38541324</ArticleId><ArticleId IdType="pmc">PMC10970637</ArticleId><ArticleId IdType="doi">10.3390/ijerph21030325</ArticleId><ArticleId IdType="pii">ijerph21030325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering A.V., van Zon S.K.R., olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;2020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA J. Am. Med. Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott H.C., Angus D.C. Enhancing recovery from sepsis: A review. JAMA J. Am. Med. Assoc. 2018;319:62&#x2013;75. doi: 10.1001/jama.2017.17687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17687</ArticleId><ArticleId IdType="pmc">PMC5839473</ArticleId><ArticleId IdType="pubmed">29297082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W., Mudara C., Vika C., Welch R., Arendse T., Dryden M., Blumberg L., Mayet N., Tempia S., Parker A., et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int. J. Infect. Dis. 2022;128:102&#x2013;111. doi: 10.1016/j.ijid.2022.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId><ArticleId IdType="pmc">PMC9800016</ArticleId><ArticleId IdType="pubmed">36587841</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoian M., Procopiescu B., &#x218;eitan S., Scarlat G. Post-COVID-19 syndrome: Insights into a novel post-infectious systemic disorder. J. Med. Life. 2023;16:195&#x2013;202. doi: 10.25122/jml-2022-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.25122/jml-2022-0329</ArticleId><ArticleId IdType="pmc">PMC10015558</ArticleId><ArticleId IdType="pubmed">36937488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanne J.H. COVID-19: US studies show racial and ethnic disparities in long covid. BMJ. 2023;380:535. doi: 10.1136/bmj.p535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p535</ArticleId><ArticleId IdType="pubmed">36878599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparyan A.Y., Ayvazyan L., Blackmore H., Kitas G.D. Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors. Rheumatol. Int. 2011;31:1409&#x2013;1417. doi: 10.1007/s00296-011-1999-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1999-3</ArticleId><ArticleId IdType="pubmed">21800117</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. World Health Organization; Geneva, Switzerland: 2021.  [(accessed on 15 July 2023)].  Available online:  https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Paleoudis E.G., Bari D.L.-D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., de Noordhout C.M., Jong C.P.-D., Cleemput I., Heede K.V.D. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy B., Fejes Z., Szentkereszty Z., S&#xfc;t&#x151; R., V&#xe1;rkonyi I., Ajzner &#xc9;., Kappelmayer J., Papp Z., T&#xf3;th A., Fagyas M. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient. Int. J. Infect. Dis. 2021;103:412&#x2013;414. doi: 10.1016/j.ijid.2020.11.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.184</ArticleId><ArticleId IdType="pmc">PMC7689308</ArticleId><ArticleId IdType="pubmed">33249290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade B.S., Siqueira S., Soares W.R.d.A., Rangel F.d.S., Santos N.O., Freitas A.d.S., da Silveira P.R., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-covid and post-covid health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigro E., Polito R., Alfieri A., Mancini A., Imperlini E., Elce A., Krustrup P., Orr&#xf9; S., Buono P., Daniele A. Molecular mechanisms involved in the positive effects of physical activity on coping with COVID-19. Eur. J. Appl. Physiol. 2020;120:2569&#x2013;2582. doi: 10.1007/s00421-020-04484-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-020-04484-5</ArticleId><ArticleId IdType="pmc">PMC7471545</ArticleId><ArticleId IdType="pubmed">32885275</ArticleId></ArticleIdList></Reference><Reference><Citation>Matic S., Popovic S., Djurdjevic P., Todorovic D., Djordjevic N., Mijailovic Z., Sazdanovic P., Milovanovic D., Ruzic Zecevic D., Petrovic M., et al. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets. PLoS ONE. 2020;15:e0241097. doi: 10.1371/journal.pone.0241097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241097</ArticleId><ArticleId IdType="pmc">PMC7774986</ArticleId><ArticleId IdType="pubmed">33382687</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarnakar R., Jenifa S., Wadhwa S. Musculoskeletal complications in long COVID-19: A systematic review. World J. Virol. 2022;11:485&#x2013;495. doi: 10.5501/wjv.v11.i6.485.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i6.485</ArticleId><ArticleId IdType="pmc">PMC9724204</ArticleId><ArticleId IdType="pubmed">36483107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. Morb. Mortal. Wkly. Rep. (MMWR) 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., Jia J.L., Li L.M., Mao H.L., Zhou X.M., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaei S.M.H., Rajebi H., Moghaddas F., Ghasemiadl M., Talari H. Chest CT in COVID-19 pneumonia: What are the findings in mid-term follow-up? Emerg. Radiol. 2020;27:711&#x2013;719. doi: 10.1007/s10140-020-01869-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10140-020-01869-z</ArticleId><ArticleId IdType="pmc">PMC7649573</ArticleId><ArticleId IdType="pubmed">33165674</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A., et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni S.E., Fabro A.T., de Albuquerque A., Ferreira E.V.M., Verrastro C.G.Y., Sawamura M.V.Y., Ribeiro S.M., Baldi B.G. Pulmonary fibrosis secondary to COVID-19: A narrative review. Expert Rev. Respir. Med. 2021;15:791&#x2013;803. doi: 10.1080/17476348.2021.1916472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2021.1916472</ArticleId><ArticleId IdType="pubmed">33902377</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan R.T., Gopalan D., Howard L., Vicente A., Park M., Manalan K., Wallner I., Marsden P., Dave S., Branley H., et al. Beyond the clot: Perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir. Med. 2020;9:107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus STATE OF THE ART REVIEW Epidemiology and Prevention. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L.N., Whyte M.B., Georgiou L., Giron G., Czuprynska J., Rea C., Vadher B., Patel R.K., Gee E., Arya R. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136:1347&#x2013;1350. doi: 10.1182/blood.2020008086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008086</ArticleId><ArticleId IdType="pmc">PMC7483432</ArticleId><ArticleId IdType="pubmed">32746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular Injury in the Brains of Patients with COVID-19. New Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG brain PET hypometabolism in patients with long, COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainland J.D., Johnson B.N., Khan R., Ivry R.B., Sobel N. Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. J. Neurosci. 2005;25:6362&#x2013;6371. doi: 10.1523/JNEUROSCI.0920-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0920-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725278</ArticleId><ArticleId IdType="pubmed">16000626</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsook D., Sava S., Becerra L. The pain imaging revolution: Advancing pain into the 21st century. Neuroscience. 2010;16:171&#x2013;185. doi: 10.1177/1073858409349902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858409349902</ArticleId><ArticleId IdType="pmc">PMC3370428</ArticleId><ArticleId IdType="pubmed">20400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis. Transl. Med. 2021;7:4&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L., Chaudhary K., Saha A., Chauhan K., Vaid A., Zhao S., Paranjpe I., Somani S., Richter F., Miotto R., et al. AKI in hospitalized patients with COVID-19. J. Am. Soc. Nephrol. 2021;32:151&#x2013;160. doi: 10.1681/ASN.2020050615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.A.S., Sampaio W.O., Alzamora A.C., Motta-Santos D., Alenina N., Bader M., Campagnole-Santos M.J. The ACE2/Angiotensin-(1-7)/Mas axis of the renin-angiotensin system: Focus on Angiotensin-(1-7) Physiol. Rev. 2018;98:505&#x2013;553. doi: 10.1152/physrev.00023.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2016</ArticleId><ArticleId IdType="pmc">PMC7203574</ArticleId><ArticleId IdType="pubmed">29351514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram K., Insel P.A. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. Br. J. Pharmacol. 2020;177:4825&#x2013;4844. doi: 10.1111/bph.15082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15082</ArticleId><ArticleId IdType="pmc">PMC7572451</ArticleId><ArticleId IdType="pubmed">32333398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirbhate E., Pandey J., Patel V.K., Kamal M., Jawaid T., Gorain B., Kesharwani P., Rajak H. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: A potential approach for therapeutic intervention. Pharmacol. Rep. 2021;73:1539&#x2013;1550. doi: 10.1007/s43440-021-00303-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00303-6</ArticleId><ArticleId IdType="pmc">PMC8236094</ArticleId><ArticleId IdType="pubmed">34176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Copur S., Berkkan M., Basile C., Tuttle K., Kanbay M. Post-acute COVID-19 syndrome and kidney diseases: What do we know? J. Nephrol. 2022;35:795&#x2013;805. doi: 10.1007/s40620-022-01296-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-022-01296-y</ArticleId><ArticleId IdType="pmc">PMC8924729</ArticleId><ArticleId IdType="pubmed">35294747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat O., Ghisdal L., Massart A., Aydin S., Goubella A., Blankoff N., Gankam F., Debelle F., Mat Q. Kidney Thrombotic Microangiopathy After COVID-19 Associated with C3 Gene Mutation. Kidney Int. Rep. 2021;6:1732&#x2013;1737. doi: 10.1016/j.ekir.2021.03.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2021.03.897</ArticleId><ArticleId IdType="pmc">PMC8028698</ArticleId><ArticleId IdType="pubmed">33851069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Larsen C.P., Hernandez-Arroyo C.F., Mohamed M.M.B., Caza T., Sharshir M., Chughtai A., Xie L., Gimenez J.M., Sandow T.A., et al. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype. J. Am. Soc. Nephrol. 2020;31:1688&#x2013;1695. doi: 10.1681/ASN.2020050558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050558</ArticleId><ArticleId IdType="pmc">PMC7460910</ArticleId><ArticleId IdType="pubmed">32561682</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty A.A., Tawhari I., Safar-Boueri L., Seif N., Alahmadi A., Gargiulo R., Aggarwal V., Usman I., Kisselev S., Gharavi A.G., et al. COVID-19-associated glomerular disease. J. Am. Soc. Nephrol. 2021;32:33&#x2013;40. doi: 10.1681/ASN.2020060804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020060804</ArticleId><ArticleId IdType="pmc">PMC7894674</ArticleId><ArticleId IdType="pubmed">33214201</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Tariq R., Jena A., Vesely E.K., Singh S., Khanna S., Sharma V. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Therap. Adv. Gastroenterol. 2022;15:17562848221118403. doi: 10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z.X., Chen X.Y., Wang J.Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 2023;14:983. doi: 10.1038/s41467-023-36223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile S., Strollo F., Mambro A., Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them? Diabetes Obes. Metab. 2020;22:2507&#x2013;2508. doi: 10.1111/dom.14170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14170</ArticleId><ArticleId IdType="pmc">PMC7436911</ArticleId><ArticleId IdType="pubmed">32790021</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Hassanein M., Khan E.G., Yaman M., Kamel M., Barbir M., Lorke D.E., Rock J.A., Everett D., Bejtullah S., et al. Diabetes and COVID-19: Short- and Long-Term Consequences. Horm. Metab. Res. 2022;54:503&#x2013;509. doi: 10.1055/a-1878-9566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9566</ArticleId><ArticleId IdType="pmc">PMC9363150</ArticleId><ArticleId IdType="pubmed">35724689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Fragkou P.C., Karofylakis E., Paneta M., Papathanasiou K., Palaiodimou L., Psarros C., Papathanasiou M., Lachanis S., Sfikakis P.P., et al. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: A case&#x2013;control study. J. Neurol. Neurosurg. Psychiatry. 2021;92:911&#x2013;912. doi: 10.1136/jnnp-2021-326587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326587</ArticleId><ArticleId IdType="pubmed">33879534</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurol. 2020;77:1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.-M., Yan W., Li C., Lu Q.-D., Liu L., Ni S.-Y., Mei H., Yuan K., Shi L., et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: Call for research priority and action. Mol. Psychiatry. 2022;28:423&#x2013;433. doi: 10.1038/s41380-022-01614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., Baldon G., Bartolomei G., Battaglia M., Battistini S., et al. Respiratory and Psychophysical Sequelae among Patients with COVID-19 Four Months after Hospital Discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman E.E., McMahon D.E., Lipoff J.B., Rosenbach M., Kovarik C., Desai S.R., Harp J., Takeshita J., French L.E., Lim H.W., et al. The spectrum of COVID-19&#x2013;associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J. Am. Acad. Dermatol. 2020;83:1118&#x2013;1129. doi: 10.1016/j.jaad.2020.06.1016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.06.1016</ArticleId><ArticleId IdType="pmc">PMC7331510</ArticleId><ArticleId IdType="pubmed">32622888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Raby E., Kumarasinghe S.P. Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses. Australas. J. Dermatol. 2021;62:141&#x2013;150. doi: 10.1111/ajd.13561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajd.13561</ArticleId><ArticleId IdType="pmc">PMC8014733</ArticleId><ArticleId IdType="pubmed">33595840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-Related Differences in Long-COVID-19 Syndrome. J. Women&#x2019;s Health. 2022;31:620&#x2013;630. doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock M.D., Chew R.F., Preiss A.J., Hadley E.C., Redfield S., McMurry J.A., Leese P.J., Girvin A.T., Crosskey M., Zhou A.G., et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat. Commun. 2023;14:2914. doi: 10.1038/s41467-023-38388-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID syndrome-associated brain fog. J. Med. Virol. 2021;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R., Freishtat N., Hill E., Rehman M., Freishtat R., Koutroulis I. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int. J. Obes. 2021;45:1163&#x2013;1169. doi: 10.1038/s41366-021-00804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00804-7</ArticleId><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey K., Ayers C.K., Kondo K.K., Saha S., Advani S.M., Young S., Spencer H., Rusek M., Anderson J., Veazie S., et al. Racial and ethnic disparities in covid-19-related infections, hospitalizations, and deaths a systematic review. Ann. Intern. Med. 2021;174:362&#x2013;373. doi: 10.7326/M20-6306.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-6306</ArticleId><ArticleId IdType="pmc">PMC7772883</ArticleId><ArticleId IdType="pubmed">33253040</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs M.M., Evans E., Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J. Natl. Med. Assoc. 2023;115:233&#x2013;243. doi: 10.1016/j.jnma.2023.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2023.01.016</ArticleId><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Price-Haywood E.G., Burton J., Fort D., Seoane L. Hospitalization and Mortality among Black Patients and White Patients with COVID-19. New Engl. J. Med. 2020;382:2534&#x2013;2543. doi: 10.1056/NEJMsa2011686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa2011686</ArticleId><ArticleId IdType="pmc">PMC7269015</ArticleId><ArticleId IdType="pubmed">32459916</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan A.P., Khan O., Meeks J.R., Boom M.L., Masud F.N., Andrieni J.D., Phillips R.A., Tiruneh Y.M., Kash B.A., Vahidy F.S. Disparities in COVID-19 hospitalizations and mortality among black and Hispanic patients: Cross-sectional analysis from the greater Houston metropolitan area. BMC Public Health. 2021;21:1330. doi: 10.1186/s12889-021-11431-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11431-2</ArticleId><ArticleId IdType="pmc">PMC8258471</ArticleId><ArticleId IdType="pubmed">34229621</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar D., Zhang Y., Zang C., Xu Z., Wang F., Weiner M.G., Carton T.W., Rothman R.L., Block J.P., Kaushal R. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: An EHR-Based Cohort Study from the RECOVER Program. J. Gen. Intern. Med. 2023;38:1127&#x2013;1136. doi: 10.1007/s11606-022-07997-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07997-1</ArticleId><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Moreno C.A., Pineda J., Bare&#xf1;o A., Espitia R., Rengifo P. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med. Infect. Dis. 2023;51:102492. doi: 10.1016/j.tmaid.2022.102492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102492</ArticleId><ArticleId IdType="pmc">PMC9640373</ArticleId><ArticleId IdType="pubmed">36368518</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda D.A.P., Gomes S.V.C., Filgueiras P.S., Corsini C.A., Almeida N.B.F., Silva R.A., Medeiros M.I.V.A.R.C., Vilela R.V.R., Fernandes G.R., Grenfell R.F.Q. Long COVID-19 syndrome: A 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans. R. Soc. Trop. Med. Hyg. 2022;116:1007&#x2013;1014. doi: 10.1093/trstmh/trac030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A., Brito-Zer&#xf3;n P., Conangla Ferr&#xed;n L., Kostov B., Moragas Moreno A., Mestres J., Sellar&#xe8;s J., Galindo G., Morera R., Basora J., et al. Long COVID-19: Proposed primary care clinical guidelines for diagnosis and disease management. Int. J. Environ. Res. Public Health. 2021;18:4350. doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); London, UK: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health among Outpatients with COVID-19 in a Multistate Health Care Systems Network-United States, March&#x2013;June 2020 [Internet] Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann. Intern. Med. 2021;174:1252&#x2013;1260. doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., et al. Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V., Dykgraaf S.H., Kidd M., Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;e854. doi: 10.1016/S2666-7568(22)00245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Moschopoulos C.D., Margalit I., Gkrania-Klotsas E., Landi F., Stahl J.P., Yahav D. ESCMID rapid guidelines for assessment management of long, COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Living with COVID-19&#x2014;Second Review [Internet]. March 2021.  [(accessed on 8 March 2024)].  Available online:  https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</Citation></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., CoviCare Study Team. Guessous I. The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization. Sci. Rep. 2022;12:14505. doi: 10.1038/s41598-022-18673-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18673-z</ArticleId><ArticleId IdType="pmc">PMC9403954</ArticleId><ArticleId IdType="pubmed">36008436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler-Davis S., Platts K., Thelwell M., Woodward A., Harrop D. A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long COVID? PLoS ONE. 2021;16:e0259533. doi: 10.1371/journal.pone.0259533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259533</ArticleId><ArticleId IdType="pmc">PMC8577752</ArticleId><ArticleId IdType="pubmed">34752489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell W.M. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) Expert Rev. Clin. Pharmacol. 2016;9:755&#x2013;770. doi: 10.1586/17512433.2016.1172960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2016.1172960</ArticleId><ArticleId IdType="pmc">PMC4917909</ArticleId><ArticleId IdType="pubmed">27045557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long covid symptoms after COVID-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly B., Vidal L., McHugh T., Woo J., Avramovic G., Lambert J.S. Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav. Immun. Health. 2022;24:100485. doi: 10.1016/j.bbih.2022.100485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashauri H.L. COVID-19 Histamine theory: Why antihistamines should be incorporated as the basic component in COVID-19 management? Health Sci. Rep. 2023;6:e1109. doi: 10.1002/hsr2.1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1109</ArticleId><ArticleId IdType="pmc">PMC9903129</ArticleId><ArticleId IdType="pubmed">36778771</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 depressive symptoms: Epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K., Yahyouche A., Haroon S., Camaradou J., Turner G. Long COVID and self-management. Lancet. 2022;399:355. doi: 10.1016/S0140-6736(21)02798-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02798-7</ArticleId><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon S., Nirantharakumar K., Hughes E.S., Subramanian A., Aiyegbusi O.L., Davies E.H., Myles P., Williams T., Turner G., Chandan J.S., et al. Therapies for Long COVID in non-hospitalised individuals: From symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study) BMJ Open. 2022;12:e060413. doi: 10.1136/bmjopen-2021-060413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-060413</ArticleId><ArticleId IdType="pmc">PMC9044550</ArticleId><ArticleId IdType="pubmed">35473737</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillen H., Bekkering G., Gijsbers S., Weygaerde Y.V., Van Herck M., Haesevoets S., Bos D.A.G., Li A., Janssens W., Gosselink R., et al. Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: A systematic review. BMC Infect Dis. 2023;23:419. doi: 10.1186/s12879-023-08374-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08374-x</ArticleId><ArticleId IdType="pmc">PMC10283248</ArticleId><ArticleId IdType="pubmed">37344767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z. Prevention of long COVID: Progress and challenges. Lancet Infect Dis. 2023;23:776&#x2013;777. doi: 10.1016/S1473-3099(23)00287-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00287-6</ArticleId><ArticleId IdType="pmc">PMC10162711</ArticleId><ArticleId IdType="pubmed">37156258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang M.H., Wu J.Y., Liu T.H., Hsu W.H., Tsai Y.W., Huang P.Y., Lai C.C. Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection. J. Med. Virol. 2023;95:e28750. doi: 10.1002/jmv.28750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28750</ArticleId><ArticleId IdType="pubmed">37185834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.M., Puskarich M.A., Cohen K., Belani H.K., Anderson B.J., Huling J.D., Tignanelli C.J., et al. Outpatient treatment of COVID-19 and the development of long COVID over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial. Lancet Infect Dis. 2023;23:1119&#x2013;1129. doi: 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler M.D. What Should We Spend to Save Lives in a Pandemic? A Critique of the Value of Statistical Life. SSRN Electron. J. 2020 doi: 10.2139/ssrn.3636550.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3636550</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmer J. What is the meaning of (statistical) life? Benefit-cost analysis in the time of COVID-19. Oxf. Rev. Econ. Policy. 2020;36:S56&#x2013;S63. doi: 10.1093/oxrep/graa022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxrep/graa022</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C.-Y., Fann J.C.-Y., Yang M.-C., Lin T.-Y., Chen H.-H., Liu J.-T., Yang K.-C. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J. Formos. Med. Assoc. 2021;120:S106&#x2013;S117. doi: 10.1016/j.jfma.2021.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2021.05.019</ArticleId><ArticleId IdType="pmc">PMC8165085</ArticleId><ArticleId IdType="pubmed">34119392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweis N.J. Revisiting the value of a statistical life: An international approach during COVID-19. Risk Manag. 2022;24:259&#x2013;272. doi: 10.1057/s41283-022-00094-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41283-022-00094-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseer S., Khalid S., Parveen S., Abbass K., Song H., Achim M.V. COVID-19 outbreak: Impact on global economy. Front. Public Health. 2023;10:1009393. doi: 10.3389/fpubh.2022.1009393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1009393</ArticleId><ArticleId IdType="pmc">PMC9923118</ArticleId><ArticleId IdType="pubmed">36793360</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P., Assal F., P&#xe9;ron J.A. The economic burden of the post-COVID-19 condition: Underestimated long-term consequences of neuropsychological deficits. J. Glob. Health. 2023;13:03019. doi: 10.7189/jogh.13.03019.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.03019</ArticleId><ArticleId IdType="pmc">PMC10159592</ArticleId><ArticleId IdType="pubmed">37141527</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M. The Costs of Long COVID. JAMA Health Forum. 2022;3:3. doi: 10.1001/jamahealthforum.2022.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach K. Is &#x201c;long Covid&#x201d; worsening the labor shortage? Brookings. 2022 doi: 10.3310/themedreview_41169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_41169</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumpias A.M., Schwartzman D., Fleming O. Long-haul COVID: Healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Serv. Res. 2022;22:1010. doi: 10.1186/s12913-022-08387-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08387-3</ArticleId><ArticleId IdType="pmc">PMC9358916</ArticleId><ArticleId IdType="pubmed">35941617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>